The Department of Defense is offering the Breast Cancer Distinguished Investigator Award to support established visionary leaders in pursuing innovative ideas to accelerate progress toward ending breast cancer. This grant is for exceptionally talented researchers, renowned for creativity and productivity, who propose research representing a fundamental shift from their prior work, addressing BCRP overarching challenges. Breast cancer research experience is not mandatory, but the application must focus on breast cancer. High-risk/high-reward projects are welcomed. Successful applicants must assemble a research team, including a breast cancer expert if needed, and at least two breast cancer consumer advocates to provide crucial, objective input on the project’s potential impact for individuals affected by the disease.
Opportunity ID: 293658
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-17-BCRP-DIA |
| Funding Opportunity Title: | DoD Breast Cancer Distinguished Investigator Award |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 1 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | May 05, 2017 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Aug 31, 2017 |
| Current Closing Date for Applications: | Aug 31, 2017 |
| Archive Date: | Sep 30, 2017 |
| Estimated Total Program Funding: | $4,800,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | The BCRP Distinguished Investigator Award enables established visionary leaders from any field to pursue innovative ideas that could accelerate progress toward ending breast cancer. These individuals should be exceptionally talented researchers who have shown that they are leaders in their field(s) through extraordinary creativity, vision, and productivity. The Principal Investigator (PI) is expected to have a renowned reputation as a researcher who has made groundbreaking contributions to advancing his/her field. He/she should have demonstrated success at forming and leading effective partnerships and collaborations. Through his/her distinguished record of research and leadership, the PI should demonstrate the potential to make unique and significant advances in breast cancer. The central feature of the Distinguished Investigator Award is that the PI must propose research that is a fundamental shift from his/her track record of research and addresses one or more BCRP overarching challenge(s). Applications that are a continuation or incremental change from the PI’s published line of research do not meet the intent of this award. High-risk/high-reward applications with limited preliminary data are welcomed, but not required. All applications must include a well-formulated, testable hypothesis based on strong scientific rationale. Experience in breast cancer research is not required; however, the application must focus on breast cancer. Individuals from other disciplines who will apply novel concepts to breast cancer are encouraged to submit. The PI is expected to assemble a research team that will provide the necessary expertise and collaborative efforts toward accomplishing the research goals. If the PI does not have experience in breast cancer, inclusion of at least one collaborator with breast cancer expertise on the research team is required. The PI’s research team must also include two or more breast cancer consumer advocates. As lay representatives, the consumer advocates must be individuals who have been diagnosed with breast cancer and are actively involved in a breast cancer advocacy organization. Their role should be independent of their employment, and they cannot be employees of any of the organizations participating in the application. The consumer advocates should have a high level of knowledge of current breast cancer issues and the necessary background or training in breast cancer research to contribute to the project. Their role should be focused on providing objective input on the research and its potential impact for individuals with, or at risk for, breast cancer. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
CDMRP Help Desk
Phone: 301-682-5507 Email: help@eBRAP.org Email:help@eBRAP.org |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 293658 Full Announcement-FY17 BCRP DIA -> BCRP_FY17_DIA_PA_GG.PDF
Packages
| Agency Contact Information: | CDMRP Help Desk Phone: 301-682-5507 Email: help@eBRAP.org Email: help@eBRAP.org |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 12.420 | PKG00232339 | May 05, 2017 | Aug 31, 2017 | View |
Package 1
Mandatory forms
293658 RR_SF424_2_0-2.0.pdf
293658 RR_Budget_1_4-1.4.pdf
293658 RR_KeyPersonExpanded_2_0-2.0.pdf
293658 PerformanceSite_2_0-2.0.pdf
293658 AttachmentForm_1_2-1.2.pdf
Optional forms
293658 RR_SubawardBudget30_1_4-1.4.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
